Project Showcase
View summaries of Tauber team projects from recent years.
Sort by year, sponsoring company, industry, or project solution.
View summaries of Tauber team projects from recent years.
Sort by year, sponsoring company, industry, or project solution.
Pfizer is currently addressing two industry-wide disruptions: an increasing difficulty to deliver blockbuster drugs and a shift towards precision medicines for cancers and rare diseases. These shifts led to two bold initiatives by CEO Albert Bourla. The first initiative focuses on accelerated delivery of medicines to the market by reducing operational cycle times across product development. The second initiative focuses on portfolio diversification, with a goal of bringing 25 new drugs to market by 2025 and an emphasis on delivering breakthrough therapies to meet unmet patient needs globally.
Andrés Fuentes-Afflick – Master of Business Administration
Jason Ji – EGL (BSE Chemical Engineering, MSE Industrial & Operations Engineering)
Ross MacRae – Senior Director, Drug Product Supply
Paul Stuart – VP, Drug Product Supply
Chris Turnbull – Informatics Lead, Drug Product Supply
Brian Talbot – Ross School of Business
Henry Wang – College of Engineering